Skip to main content
Equibles
KNSA $77.09 +1.02%
KNSA logo
KNSA · Kiniksa Pharmaceuticals International, plc
Track KNSA — free

Use KNSA with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research KNSA.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$77.09 +0.78 (+1.02%) At close · Oct 6
Russell 2000 member Rebalance outlook locked
Market Cap
$11.72B
Shares
156.05M
Volume · Oct 6 378.74K Avg daily vol (3M) 595.2K
All webcasts

Earnings call · FY2026 Q1

Kiniksa Pharmaceuticals International, plc (KNSA) Q1 2026 Earnings Call

Concluded Apr 28, 2026
Apr 28, 2026 0 turns
Period
FY2026 Q1
Runtime
—
Sources
2 artifacts
8-K 10-Q

Executive readout · one minute

Webcast research workspace

Read the call alongside every captured source. 8-K earnings release, 10-Q stay in one workspace.

Research coverage

2 live sources

Open each available source without leaving this research workspace.

Revenue $214.27M +55.5% YoY
Diluted EPS $0.27 +145.5% YoY
Net income $22.59M +164.6% YoY

Research materials

Open the source you need; every reader stays inside this workspace.

8-K earnings release Filed Apr 28, 2026 10-Q report Filed Apr 28, 2026
Full-screen source Call document

KNSA transcript alerts

Kiniksa Pharmaceuticals International, plc

Create a free account or sign in to receive transcript alerts at your email address.

Continue to sign in
Read transcripts like this one from Claude, ChatGPT or your own code with the earnings call transcript API →